|Last Price||0.61||Max Price||1.60|
|Min Price||0.55||1 Year return||-59.06|
|Avg. Target||1.10||Expected Return|
|Annual report 2017|
OncoMethylome Sciences is a molecular diagnostics company developing gene methylation tests for early cancer detection and personalized treatment decisions. OncoMethylome Sciences was founded in 2003 and is headquartered in Belgium. Its offices and laboratories are located in Belgium, the Netherlands and the USA (Durham, NC). OncoMethylome Sciences’ stocks are traded on the Euronext Amsterdam and the company is a component of the Local Securities-index (ISIN: BE0003844611/ Mnemo: ONCOA).